These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 17519642

  • 1. Olanzapine therapy in anorexia nervosa: psychobiological effects.
    Brambilla F, Garcia CS, Fassino S, Daga GA, Favaro A, Santonastaso P, Ramaciotti C, Bondi E, Mellado C, Borriello R, Monteleone P.
    Int Clin Psychopharmacol; 2007 Jul; 22(4):197-204. PubMed ID: 17519642
    [Abstract] [Full Text] [Related]

  • 2. Lack of efficacy of psychological and pharmacological treatments of disorders of eating behavior: neurobiological background.
    Brambilla F, Amianto F, Dalle Grave R, Fassino S.
    BMC Psychiatry; 2014 Dec 24; 14():376. PubMed ID: 25539757
    [Abstract] [Full Text] [Related]

  • 3. Effects of cognitive-behavioral therapy on Eating Disorders: neurotransmitter secretory response to treatment.
    Brambilla F, Dalle Grave R, Calugi S, Marchesini G, Baroni S, Marazziti D.
    Psychoneuroendocrinology; 2010 Jun 24; 35(5):729-37. PubMed ID: 19962832
    [Abstract] [Full Text] [Related]

  • 4. Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: a randomized, double-blind, placebo-controlled trial.
    Bissada H, Tasca GA, Barber AM, Bradwejn J.
    Am J Psychiatry; 2008 Oct 24; 165(10):1281-8. PubMed ID: 18558642
    [Abstract] [Full Text] [Related]

  • 5. Perfectionism in anorexia nervosa: variation by clinical subtype, obsessionality, and pathological eating behavior.
    Halmi KA, Sunday SR, Strober M, Kaplan A, Woodside DB, Fichter M, Treasure J, Berrettini WH, Kaye WH.
    Am J Psychiatry; 2000 Nov 24; 157(11):1799-805. PubMed ID: 11058477
    [Abstract] [Full Text] [Related]

  • 6. Combined cognitive-behavioral, psychopharmacological and nutritional therapy in eating disorders. 1. Anorexia nervosa--restricted type.
    Brambilla F, Draisci A, Peirone A, Brunetta M.
    Neuropsychobiology; 1995 Nov 24; 32(2):59-63. PubMed ID: 7477800
    [Abstract] [Full Text] [Related]

  • 7. An open trial of olanzapine in anorexia nervosa.
    Barbarich NC, McConaha CW, Gaskill J, La Via M, Frank GK, Achenbach S, Plotnicov KH, Kaye WH.
    J Clin Psychiatry; 2004 Nov 24; 65(11):1480-2. PubMed ID: 15554759
    [Abstract] [Full Text] [Related]

  • 8. A placebo-controlled pilot study of adjunctive olanzapine for adolescents with anorexia nervosa.
    Kafantaris V, Leigh E, Hertz S, Berest A, Schebendach J, Sterling WM, Saito E, Sunday S, Higdon C, Golden NH, Malhotra AK.
    J Child Adolesc Psychopharmacol; 2011 Jun 24; 21(3):207-12. PubMed ID: 21663423
    [Abstract] [Full Text] [Related]

  • 9. Double-blind placebo-controlled trial of quetiapine in anorexia nervosa.
    Powers PS, Klabunde M, Kaye W.
    Eur Eat Disord Rev; 2012 Jul 24; 20(4):331-4. PubMed ID: 22535517
    [Abstract] [Full Text] [Related]

  • 10. The effectiveness of cognitive behavioral therapy on changing eating disorder symptoms and psychopathology of 32 anorexia nervosa patients at hospital discharge and one year follow-up.
    Bowers WA, Ansher LS.
    Ann Clin Psychiatry; 2008 Jul 24; 20(2):79-86. PubMed ID: 18568579
    [Abstract] [Full Text] [Related]

  • 11. The Yale-Brown-Cornell eating disorder scale in women with anorexia nervosa: what is it measuring?
    Jordan J, Joyce PR, Carter FA, McIntosh VV, Luty SE, McKenzie JM, Frampton CM, Bulik CM.
    Int J Eat Disord; 2009 Apr 24; 42(3):267-74. PubMed ID: 18951459
    [Abstract] [Full Text] [Related]

  • 12. Deep brain stimulation of the subcallosal cingulate for treatment-refractory anorexia nervosa: 1 year follow-up of an open-label trial.
    Lipsman N, Lam E, Volpini M, Sutandar K, Twose R, Giacobbe P, Sodums DJ, Smith GS, Woodside DB, Lozano AM.
    Lancet Psychiatry; 2017 Apr 24; 4(4):285-294. PubMed ID: 28238701
    [Abstract] [Full Text] [Related]

  • 13. Growth hormone and insulin-like growth factor 1 secretions in eating disorders: Correlations with psychopathological aspects of the disorders.
    Brambilla F, Santonastaso P, Caregaro L, Favaro A.
    Psychiatry Res; 2018 May 24; 263():233-237. PubMed ID: 29179911
    [Abstract] [Full Text] [Related]

  • 14. Atypical antipsychotics as augmentation therapy in anorexia nervosa.
    Marzola E, Desedime N, Giovannone C, Amianto F, Fassino S, Abbate-Daga G.
    PLoS One; 2015 May 24; 10(4):e0125569. PubMed ID: 25922939
    [Abstract] [Full Text] [Related]

  • 15. A double-blind, placebo-controlled study of risperidone for the treatment of adolescents and young adults with anorexia nervosa: a pilot study.
    Hagman J, Gralla J, Sigel E, Ellert S, Dodge M, Gardner R, O'Lonergan T, Frank G, Wamboldt MZ.
    J Am Acad Child Adolesc Psychiatry; 2011 Sep 24; 50(9):915-24. PubMed ID: 21871373
    [Abstract] [Full Text] [Related]

  • 16. The role of olanzapine in the treatment of anorexia nervosa.
    Dunican KC, DelDotto D.
    Ann Pharmacother; 2007 Jan 24; 41(1):111-5. PubMed ID: 17190846
    [Abstract] [Full Text] [Related]

  • 17. [Olanzapine in the treatment of adolescents with anorexia nervosa].
    Hein IM, Huyser C.
    Tijdschr Psychiatr; 2010 Jan 24; 52(6):417-21. PubMed ID: 20544600
    [Abstract] [Full Text] [Related]

  • 18. Clinical, psychopathological and personality correlates of interoceptive awareness in anorexia nervosa, bulimia nervosa and obesity.
    Fassino S, Pierò A, Gramaglia C, Abbate-Daga G.
    Psychopathology; 2004 Jan 24; 37(4):168-74. PubMed ID: 15237246
    [Abstract] [Full Text] [Related]

  • 19. Combined cognitive-behavioral, psychopharmacological and nutritional therapy in eating disorders. 2. Anorexia nervosa--binge-eating/purging type.
    Brambilla F, Draisci A, Peirone A, Brunetta M.
    Neuropsychobiology; 1995 Jan 24; 32(2):64-7. PubMed ID: 7477801
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the efficacy and safety of olanzapine as an adjunctive treatment for anorexia nervosa in adolescent females: a randomized, double-blind, placebo-controlled trial.
    Spettigue W, Buchholz A, Henderson K, Feder S, Moher D, Kourad K, Gaboury I, Norris M, Ledoux S.
    BMC Pediatr; 2008 Jan 31; 8():4. PubMed ID: 18234120
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.